Similar articles

• A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.

  Chen JL, Chen J, Qiao SB, Guo YL, Wu YJ, Dai J, Yuan JQ, Qin XW, Yang YJ, Gao RL. Chen JL, et al. Chin Med J (Engl). 2006 Mar 5;119(5):355-9. Chin Med J (Engl). 2006. PMID: 16542576 Clinical Trial.
• Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis.

  Ferrari E, Benhamou M, Cerboni P, Marcel B. Ferrari E, et al. J Am Coll Cardiol. 2005 Feb 1;45(3):456-9. doi: 10.1016/j.jacc.2004.11.041. J Am Coll Cardiol. 2005. PMID: 15680728
• Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry).

  Planer D, Beyar R, Almagor Y, Banai S, Guetta V, Miller H, Kornowski R, Brandes S, Krakover R, Solomon M, Lotan C. Planer D, et al. Am J Cardiol. 2008 Apr 1;101(7):953-9. doi: 10.1016/j.amjcard.2007.11.043. Epub 2008 Feb 11. Am J Cardiol. 2008. PMID: 18359314
• Drug-eluting stent fracture and acute coronary syndrome.

  Chhatriwalla AK, Cam A, Unzek S, Bhatt DL, Raymond RE, Lincoff AM, Whitlow PL, Ellis SG, Tuzcu EM, Kapadia SR. Chhatriwalla AK, et al. Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):166-71. doi: 10.1016/j.carrev.2009.02.003. Cardiovasc Revasc Med. 2009. PMID: 19595398 Review.
• Stent thrombosis in the era of drug eluting stents.

  Kawaguchi R, Angiolillo DJ, Futamatsu H, Suzuki N, Bass TA, Costa MA. Kawaguchi R, et al. Minerva Cardioangiol. 2007 Apr;55(2):199-211. Minerva Cardioangiol. 2007. PMID: 17342038 Review.